Page last updated: 2024-10-21

n-(3-(aminomethyl)benzyl)acetamidine and Endomyocardial Fibrosis

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Endomyocardial Fibrosis in 1 studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Endomyocardial Fibrosis: A condition characterized by the thickening of the ventricular ENDOCARDIUM and subendocardium (MYOCARDIUM), seen mostly in children and young adults in the TROPICAL CLIMATE. The fibrous tissue extends from the apex toward and often involves the HEART VALVES causing restrictive blood flow into the respective ventricles (CARDIOMYOPATHY, RESTRICTIVE).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, X1
Tan, Y1
Xu, B1
Lu, L1
Zhao, M1
Ma, J1
Liang, H1
Liu, J1
Yu, S1

Other Studies

1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and Endomyocardial Fibrosis

ArticleYear
GPR30 Attenuates Myocardial Fibrosis in Diabetic Ovariectomized Female Rats: Role of iNOS Signaling.
    DNA and cell biology, 2018, Volume: 37, Issue:10

    Topics: Amidines; Animals; Apoptosis; Blood Glucose; Cell Proliferation; Diabetes Mellitus, Experimental; Di

2018